916591-01-0

916591-01-0 structure

Name: Tedalinab
Chemical Name: (1R,7S)-3-(2,4-Difluorophenyl)-N-(2-methyl-2-propanyl)-3,4-diazatricyclo[5.2.1.02,6]deca-2(6),4-diene-5-carboxamide
CAS Number: 916591-01-0
Molecular Formula: C₁₉H₂₁F₂N₃O
Molecular Weight: 345.38600
Catalog: Signaling Pathways GPCR/G Protein Cannabinoid Receptor
Create Date: 2016-12-08 07:50:42
Modify Date: 2025-08-25 17:19:49
Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1].

Name	(1R,7S)-3-(2,4-Difluorophenyl)-N-(2-methyl-2-propanyl)-3,4-diazatricyclo[5.2.1.02,6]deca-2(6),4-diene-5-carboxamide

Description	Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1].
Related Catalog	Research Areas >> Inflammation/Immunology Signaling Pathways >> GPCR/G Protein >> Cannabinoid Receptor
Target	CB2
References	[1]. Glenmark’s molecule for neuropathic pain, osteoarthritis - GRC 10693, successfully completes Phase I trials.